Home > Boards > Stock Clubs > Market Trends and Strategies > 10-Baggas Factory 10

$MJNA Medical Marijuana, Inc. (MJNA), through its subsidiaries

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SpotOnTrade Member Profile
 
Followed By 814
Posts 138,471
Boards Moderated 7
Alias Born 08/13/10
160x600 placeholder
Incyte Says FDA Approves Jakafi in Chronic Graft-Versus-Host Disease
By Michael Dabaie
STOXX Europe 50 Index Ends 0.96% Higher at 3547.18 -- Data Talk
EURO STOXX 50 Index Ends 1.29% Higher at 4150.19 -- Data Talk
FTSE 100 Index Ends 1.47% Higher at 7083.37 -- Data Talk
DAX Ends 1.03% Higher at 15506.74 -- Data Talk
CAC 40 Index Ends 1.29% Higher at 6637.00 -- Data Talk
STOXX Europe 600 Index Ends 0.99% Higher at 463.20 -- Data Talk
FTSE 100 Closes Higher on Wednesday But BOE Meeting Looms
FedEx Working With Paccar, Aurora on Autonomous Truck Program
U.S. Ethanol Stocks Snap Streak
Top Company News of the Day
U.S. Oil Inventories Fall as Refineries Restart After Hurricane
GM, Amazon to Introduce OnStar Guardian Skill for Amazon Alexa
FedEx Down Over 8%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
Medtronic Begins Pediatric Clinical Trial of Spinal Tether for Treatment of Scoliosis
New Home Sales on Tap -- Data Week Ahead
Bed Bath & Beyond Expands Partnership with DoorDash
VC Daily: Indian Ed-Tech Startup Boosts U.S. Expansion With Summer Deals
FTSE Rises, Halma Reports Strong Progress, But Peel Hunt Retains Reduce Rating
Pro Bankruptcy Briefing: J&J Beats Injury Lawyers on Talc Bankruptcy; Judge Questions Talc Supplier's Chapter 11 Vote
Taper Talk in Focus at Fed Meeting
Atlas Air Expands FedEx Air-Freighter Contract
American Airlines Says Justice Dept Antitrust Suit Is Without Merit
EDF in Talks With GE Over Nuclear Activities -- Update
EDF in Talks With GE Over Nuclear Activities
AES Names Coughlin Finance Chief as Pimenta Resigns
SpotOnTrade   Wednesday, 10/21/15 11:11:33 AM
Re: SpotOnTrade post# 173962
Post # of 185250 
$MJNA Medical Marijuana, Inc. (MJNA), through its subsidiaries and investment holdings, offers a portfolio of products, services, technology and businesses for the medical marijuana and industrial hemp markets. The Company is in the development-stage. The Company's products range from cannabinoid-based products, to whole plant or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries. The Company's services include medical clinic management, and the capitalization and development of cannabis and hemp industries business. Its services include development of cannabinoid-based health and wellness products, and the development of medical-grade cannabinoid compounds. MJNA services include the licensing of its testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal cannabinoid industry.

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences